Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1319 |
|
Actual shortage: | 60 (5%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 36 (3%) | |
Resolved: | 1223 (93%) | |
Discontinuation Reports |
287 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 283 (99%) | |
Reversed: | 2 (1%) | |
Late reports |
210 (13%) |
|
Overdue reports |
27 (44%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2019-05-09 | 2020-09-18 | 83687 |
PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2019-06-28 | 2019-09-03 | 87956 |
PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-06-28 | 2019-09-04 | 87965 |
PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2019-06-28 | 2019-09-04 | 87968 |
PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2019-07-31 | 2020-05-19 | 90464 |
PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2017-09-07 | 2017-10-11 | 21551 |
PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2017-09-07 | 2018-04-19 | 21554 |
PMS-IRBESARTAN | 300MG | TABLET | Resolved | 2017-09-07 | 2018-04-19 | 21558 |
PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2019-11-15 | 2021-06-18 | 98811 |
PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2021-12-08 | 2023-06-09 | 150725 |
PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2023-08-10 | 2023-08-28 | 201548 |
PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2024-12-04 | 2024-12-20 | 244825 |
PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2025-02-05 | 2025-04-01 | 249588 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2024-08-23 | 2024-09-30 | 235745 |
PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-06-11 | 2019-09-04 | 86225 |
PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-06-28 | 2020-09-18 | 87959 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2019-06-28 | 2019-12-24 | 87971 |
PMS-IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-24 | 2018-04-27 | 4213 |
PMS-IRBESARTAN-HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-24 | 2017-09-19 | 4216 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2017-04-20 | 2017-06-09 | 7373 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2020-06-17 | 2020-06-17 | 118093 |
PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2020-06-15 | 2021-10-27 | 117714 |
PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-06-21 | 2021-06-21 | 141302 |
PMS-DOCUSATE SODIUM | 250MG | SYRUP | Discontinued | 2020-06-15 | 2021-10-27 | 117730 |
PMS-DOCUSATE SODIUM | 20MG | SYRUP | Discontinued | 2021-11-16 | 2021-11-16 | 149365 |
PMS-DOCUSATE SODIUM DROPS 10MG/ML | 10MG | DROPS DROPS | Discontinued | 2020-06-15 | 2021-10-27 | 117733 |
PMS-DOMPERIDONE | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117760 |
PMS-DORZOLAMIDE-TIMOLOL | 20MG 5MG | SOLUTION | Discontinued | 2020-06-16 | 2020-06-16 | 118026 |
PMS-DUTASTERIDE | 0.5MG | CAPSULE | Discontinued | 2022-12-09 | 2022-12-09 | 177691 |
PMS-DUTASTERIDE | 0.5MG | CAPSULE | Discontinued | 2022-12-09 | 2022-12-09 | 177694 |
PMS-ELETRIPTAN | 20MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117933 |
PMS-ELETRIPTAN | 40MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118162 |
PMS-ELETRIPTAN | 40MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118165 |
PMS-ENALAPRIL | 16MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6041 |
PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6044 |
PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6047 |
PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2021-11-16 | 2021-11-16 | 149403 |
PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2019-06-28 | 2019-06-28 | 87934 |
PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2019-06-28 | 2019-06-28 | 87938 |
PMS-EPIRUBICIN | 2MG | SOLUTION | Discontinued | 2021-11-16 | 2021-11-16 | 149400 |